Gemtuzumab (Anti-Siglec-3 / CD33)

Gemtuzumab (Anti-Siglec-3 / CD33) a monoclonal antibody targeting CD33 antigen, which present on the human leukemic myeloblasts of acute myeloid leukemia (AML). It can be used as antibody-drug conjugate for the treatment of AML. This biosimilar antibody is used for research only. MW :145.22 KD.

Product Details
Species Reactivity	Human
Host/Isotype	Human IgG4
Class	Monoclonal
Type	Recombinant Antibody
Immunogen	Human CD33
Clone	Gemtuzumab biosimilar
Conjugate	Unconjugated
Purity	99%
Molecular Weight	145.22 KD
Protein Concentration	1mg/ml
Storage Condition	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer	100mM Pro-Ac, 20mM Arg-Ac, pH 5.0